REFERENCES
1. Libby P, Pasterkamp G, Crea F, Kyung Jang Ik. Reassessing the Mechanisms of Acute Coronary Syndromes: The “Vulnerable Plaque” and Superficial Erosion. Circ Res 2019; 124: 150-160.
2. Braunwald, E. and D.A. Morrow, Unstable angina: is it time for a requiem? Circulation 2013; 127: 2452-7.
3. Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs, J, Bhatt DL et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. Eur Heart J 2020; 00 1-79 doi:10.1093/eurheartj/ehaa575
4. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37:267-315.
5. O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, Winter RJ, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2008; 300: 71-80.
6. O’Donoghue ML, Morrow DA, Cannon CP, Jarolim P, Desai NR, Sherwood MW, et al. Multimarker Risk Stratification in Patients With Acute Myocardial Infarction. J Am Heart Assoc 2016;5:e002586.
7. Morawiec B, Kawecki D. Copeptin: a new marker in cardiology. J Cardiovasc Med (Hagerstown) 2013;14:19-25.
8. Lui CT, Lam H, Cheung KH, Yip SF, Tsui KL, Kam CW, et al. Role of copeptin in dual-cardiac marker strategy for patients with chest pain presented to ED. Am J Emerg Med 2015;33:1732-6.
9. Khan SQ, Dhillon OS, O’Brien RJ, Struck J, Quinn PA, Morgenthaler NG, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007;115: 2103-10.
10. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54: 60-8.
11. Eagle KA, Lim Mj, Dabbaus OH, Pieper KS, Goldberg RJ, Van de Werf FV, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291:2727-33.
12. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1: 219-27.
13. Basra SS, Virani SS, Paniagua D, Kar B, Jneid H. Acute Coronary Syndromes: Unstable Angina and Non-ST Elevation Myocardial Infarction. Heart Fail Clin 2016;12:31-48.
14. Hedayati T, Yadav N, Khanagavi J. Non-ST-Segment Acute Coronary Syndromes. Cardiol Clin 2018;36:37-52.
15. Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail 2010; 16 Suppl 1:37-44.
16. Maisel A, Mueller C, Neath SX, Christenson RH, Morgenthaler Ng, McCord J, et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol 2013; 62:150-160.
17. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010;55:2096-106.
18. Wildi K, Zellweger C, Twerenbold R, et al. Incremental value of copeptin to highly sensitive cardiac Troponin I for rapid rule-out of myocardial infarction. Int J Cardiol 2015;190:170-176.
19. Balmelli C, Meune C, Twerenbold R, Jaeger C, Reichlin T, Haaf P, et al. Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. Am Heart journal 2013;166:30-37.
20. Charpentier S, Lepage B, Maupas-Schwalm F, Cinq-Frais C, Bichard-Bréaud M, Botella JM, et al. Copeptin improves the diagnostic performance of sensitive troponin I-Ultra but cannot rapidly rule out non-ST-elevation myocardial infarction at presentation to an emergency department. Ann Emerg Med 2013; 61:549-558.
21. O’Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, et al. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol 2014;63:1644-53.
22. Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Harrasser B, Mair J, et al. Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction. Heart 2013; 99:1525-9.
23. von Haehling S, Papassotiriou J, Morgenthaler NG, Nagel E, Gawaz M, Bigalke B, et al. Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease. Int J Cardiol 2012; 162:27-32.
24. Zellweger C, Wildi K, Twerenbold R, T Reichlin, A Naduvilekoot, J D Neuhauset, al. Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction. Int J Cardiol 2015; 190:190-197.
25. Afzali D, Erren M, Hermann-Joseph P, Vollert JO, Hertel S, Waltenberger J, et al. Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes. Clin Res Cardiol 2013; 102:755-63.
26. Chenevier-Gobeaux C, Sebbane M, Meune C, Lefebvre S, Dupuy AM, Lefèvreet G, al. Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments. BMJ Open 2019;9:e023994.
27. Morawiec, B. Kawecki D, Przywara-Chowaniec B, Opara M, Muzyk P, Ho L, et al. Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome. Dis Markers 2018; 24: 6597387.